BD 2142210 - PowerLoc MAX PAK Safety Infusion Set, 22G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

BD 2142210 - PowerLoc MAX PAK Safety Infusion Set, 22G x 1", Without Y-Injection Site, 5/CS (Temp Sensitive; Non-Returnable) (Continental US Only)

The BD 2142210 PowerLoc MAX PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible subcutaneously implanted vascular ports. The set features a 22-gauge non-coring needle with a 1-inch length and is configured without a Y-injection site.

The PowerLoc MAX system provides a fluid pathway for administering compatible medications and solutions, withdrawing blood specimens, flushing implanted ports, and delivering contrast media through appropriately rated power-injectable ports. The 22-gauge needle provides a smaller profile for clinical applications where the prescribed therapy and required flow rate do not require a larger-gauge access device.

The 1-inch needle length is intended for implanted ports positioned at a moderate depth beneath the skin. Appropriate needle-length selection helps ensure secure septum access while supporting stable positioning and effective dressing application.

An integrated safety mechanism is incorporated into the needle base. During port deaccessing, the needle is withdrawn into the protective housing so that the needle point is covered and secured. This single-step safety feature is designed to help reduce accidental needlestick exposure during removal, handling, transportation, and disposal.

The low-profile, wingless base supports dressing placement and ongoing access-site management. Its padded, non-absorbent footprint is designed to promote patient comfort, while the rotating needle hub allows clinicians to position the tubing according to the treatment environment and dressing configuration.

The MAX PAK presentation provides an organized, all-in-one solution intended to simplify the multi-step sterile port-access preparation process. BD 2142210 is supplied five sets per case.

Key Benefits

• 22-gauge non-coring needle supports access to compatible implanted vascular ports.
• One-inch needle length accommodates appropriately positioned ports with moderate tissue depth over the septum.
• Smaller needle profile may be suitable for therapies that do not require a larger-gauge access device.
• Power-injectable design supports compatible contrast-enhanced imaging procedures.
• Supports power-injection flow rates up to 2 mL per second when used within approved system limits.
• Integrated safety mechanism covers and secures the needle point following removal.
• Single-step safety activation helps reduce accidental needlestick exposure.
• Low-profile base supports secure dressing placement and routine access-site care.
• Wingless construction helps reduce unnecessary bulk beneath the dressing.
• Non-absorbent padded footprint is designed to promote patient comfort.
• Clear base supports visual observation of the access site during therapy.
• Rotating needle hub supports convenient tubing positioning and maneuverability.
• Stable needle base helps maintain access-device positioning during treatment.
• Compatible with appropriate implanted port configurations, including suitable dual-lumen ports.
• Configuration without a Y-injection site provides a direct fluid pathway.
• MAX PAK format helps organize supplies required for sterile port-access preparation.
• Five-per-case packaging supports controlled clinical inventory management.

Compatibility and Applications

The BD 2142210 PowerLoc MAX PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood specimen collection, port flushing, long-term infusion therapy, blood product administration, and contrast-media delivery during compatible diagnostic imaging procedures.

The 22-gauge configuration may be selected when a smaller needle diameter and moderate flow capability are appropriate for the prescribed therapy. Selection should consider the implanted port instructions, required medication or fluid viscosity, intended flow rate, clinical procedure, and professional judgment.

When used for power injection, the implanted port, access needle, tubing, connectors, extension components, and every other part of the fluid pathway must be specifically rated for power injection. The pressure and flow rate must not exceed the lowest-rated component within the complete system.

Compatible 22-gauge PowerLoc MAX configurations support power-injection flow rates up to 2 mL per second under manufacturer-specified operating conditions. The actual permitted rate may be lower depending on the implanted port, connected equipment, contrast medium, and facility protocol.

The 1-inch needle length may be appropriate when a 0.75-inch needle is insufficient to access the port septum but a 1.5-inch needle would provide unnecessary additional length. Clinicians must assess tissue depth and port position before choosing the access needle.

The set does not include a Y-injection site. It is suitable for workflows that use a direct tubing pathway and do not require a secondary medication or injection-access point.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2142210 should be used only by healthcare professionals who are trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status.
• Assess the position and depth of the implanted port before selecting the 1-inch needle.
• Verify that the 22-gauge configuration provides sufficient flow capability for the intended procedure.
• Inspect the sterile package for moisture, punctures, damage, contamination, or compromised integrity.
• Prepare the port-access site using the antiseptic procedure required by institutional policy.
• Prime the infusion set completely with an approved solution using aseptic technique.
• Remove all air from the fluid pathway before connecting the set to the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to facility policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and institutional protocol.
• Position the rotating hub and tubing to reduce pressure, pulling, twisting, and dressing disruption.
• Secure the access set and apply an approved sterile dressing.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other complications.
• Confirm power-injection eligibility before connecting the set to a power injector.
• Do not exceed 2 mL per second or the lower operating limit of any connected component.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle point is fully covered and secured within the protective base.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or other abnormalities develop at the access site.

Certifications and Safety Standards

The BD 2142210 PowerLoc MAX PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The product is supplied sterile and intended for single use. Maintaining package integrity and following appropriate aseptic technique are essential for preserving the sterile condition before use.

The integrated safety mechanism supports occupational exposure-control procedures by covering and securing the needle point after removal. This feature does not replace proper sharps handling, personal protective equipment, clinician training, or immediate disposal in an approved sharps container.

The non-coring needle is designed to access the septum of a compatible implanted vascular port while helping preserve septum integrity. The device should be incorporated into facility procedures covering port assessment, sterile access, securement, dressing management, infusion administration, power injection, deaccessing, and sharps disposal.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, pressure limitations, flow-rate limits, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional port-access needles without safety features, the BD PowerLoc MAX includes an integrated mechanism that covers and secures the needle point during deaccessing. This can help reduce accidental needlestick exposure between needle removal and final disposal.

Compared with winged non-coring needle sets, the wingless and low-profile base may simplify dressing placement and improve visibility around the access site. Winged designs may remain preferable when clinicians require wings for insertion control or stabilization.

Compared with non-power-injectable port-access sets, the PowerLoc MAX supports compatible power-injection procedures when used with an approved power-injectable port and within all manufacturer-specified operating limits.

Compared with sets containing a Y-injection site, BD 2142210 provides a direct fluid pathway without an additional secondary access point. This may reduce unnecessary connections when secondary medication administration is not required.

Compared with 19-gauge and 20-gauge PowerLoc MAX configurations, the 22-gauge needle provides a smaller diameter but a lower maximum power-injection flow rate. The 22-gauge configuration supports up to 2 mL per second, while compatible 19-gauge and 20-gauge models may support higher flow rates.

Compared with the 0.75-inch option, the 1-inch needle can accommodate ports positioned beneath a greater tissue depth. Compared with a 1.5-inch configuration, the 1-inch needle may provide a lower access profile when the additional length is unnecessary.

Alternative safety infusion sets may vary in gauge, needle length, power-injection capability, safety activation method, base design, padding, tubing configuration, Y-site availability, included preparation components, and package quantity. BD 2142210 combines a 22-gauge, 1-inch non-coring needle with a low-profile padded base, integrated safety mechanism, direct tubing configuration, and MAX PAK presentation.

Typical User Profile and Application Scenarios

The BD 2142210 PowerLoc MAX PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified clinical personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted ports are routinely accessed.

The product may be selected for patients whose implanted port requires a 1-inch access needle and whose prescribed treatment or diagnostic procedure is compatible with a 22-gauge device.

Typical application scenarios include medication infusion, antibiotic therapy, hydration, selected chemotherapy treatments, blood specimen collection, routine port maintenance, and power injection of contrast media at compatible flow rates.

The configuration without a Y-injection site is particularly relevant when a direct connection is preferred and the treatment plan does not require secondary access through the infusion tubing.

Best Practices for Use and Maintenance

The BD 2142210 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on proper storage, product selection, sterile preparation, port-access technique, site monitoring, safety activation, and disposal.

• Store unopened sets under the environmental conditions specified by the manufacturer.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2142210 catalog number before opening the package.
• Confirm the 22-gauge size, 1-inch length, and absence of a Y-injection site.
• Assess the patient's tissue depth and port position before selecting the needle length.
• Confirm that the required therapy and flow rate are appropriate for a 22-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the tubing completely before connecting it to the implanted port.
• Stabilize the port during insertion and needle removal.
• Use the rotating hub to position the tubing without creating tension at the access site.
• Monitor the site throughout therapy for infiltration, extravasation, infection, leakage, or displacement.
• Verify the power-injectable status of the complete access system before a powered procedure.
• Never exceed the lowest pressure or flow-rate limit of any connected component.
• Do not bend, cut, modify, repair, or otherwise alter the device.
• Do not reuse, clean, resterilize, or reprocess the single-use set.
• Verify complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2142210 PowerLoc MAX PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 22-gauge size, 1-inch needle length, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every connected component are specifically rated for power injection. The permitted pressure, flow rate, contrast-media viscosity, and other operating conditions must be verified before beginning the procedure.

Compatible 22-gauge PowerLoc MAX configurations support power-injection flow rates up to 2 mL per second when used under the conditions specified by the manufacturer. The lowest-rated component within the complete system determines the maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, tissue injury, leakage, port damage, interrupted treatment, or other complications.

Because this model does not include a Y-injection site, it does not provide a secondary medication-access point within the tubing. Clinical teams should confirm that the direct configuration is suitable for the intended procedure before opening the package.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp even after the needle point is covered and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. Distributor listings identify this configuration as temperature sensitive and non-returnable. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, and return conditions before ordering.

How to Order

Select the BD 2142210 - PowerLoc MAX PAK Safety Infusion Set without Y-Injection Site, 22G x 1" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.